Chemed Corporation (NYSE: CHE) reported Q4 EPS of $5.25, $0.17 better than the analyst estimate of $5.08. Revenue for the quarter came in at $541 million versus the consensus estimate of $543.18 million.

GUIDANCE:

Chemed Corporation sees FY2022 EPS of $19.10-$19.50, versus the consensus of $19.31.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.